SARcode Corporation is a private San Francisco based biopharmaceutical company engaged in the development of a novel class of small molecule lymphocyte function-associated antigen-1 (LFA-1; CD11a/CD18; Î±LÎ²2) antagonists as a topical agent for the treatment of significant unmet medical needs in ophthalmology, dermatology and other inflammatory diseases.
Current Team (3)Update
Funding Rounds (2) - $73MUpdate
Board Members and Advisors (5)Update
Since 1974, Sofinnova Ventures has partnered with entrepreneurs to secure initial funding, build...
Alta Partners is a leading venture capital firm in life sciences, funding over 130 companies in...
Clarus Ventures is a life sciences venture capital firm.
1000 Marina Blvd.
Brisbane, CA 94005